July 3, 2015

Web-Based Portals Can Inform and Empower
Cure – July 1
“Our patients might have a greater need [for the portal] simply because of the nature of their illness,” explained Sheila Ferrall, Director of Nursing Practice, Education and Clinical Effectiveness at Moffitt Cancer Center in Tampa, Florida.

Thomas steps aside as fire district chair
KeysNews.com – July 1
During the week, he is receiving radiation treatment at H. Lee Moffitt Cancer Center & Research Institute in Tampa. But, Thomas said, he would be home the majority of the weekends.

New drug trains immune system to attack tumor and stop lung cancer
WNDU via Ivanhoe Broadcast News – June 30
Ben Creelan, MD, Assistant Faculty, Medical Oncologist at Moffitt Cancer Center in Tampa, Florida said, “It’s a real game changer to be able to have a treatment which works for years in some patients.”

DESPITE RICK SCOTT REJECTION, MARK SHARPE SAYS TAMPA INNOVATION ALLIANCE IS RIGHT ON COURSE
Florida Politics – June 30
Innovative districts have been described as geographic areas where “anchor” institutions and companies cluster and connect with start-ups, business incubators and accelerators. Ideally they’re also physically compact, transit-accessible, and technically wired and offer mixed-use housing, office, and retail. Anchor institutions here include USF, Florida Hospital Tampa, Moffitt Cancer Center and Busch Gardens.

Despite Rick Scott rejection, Mark Sharpe says Tampa Innovation Alliance is right on course
SaintPetersBlog via Florida Politics – June 30
Innovative districts have been described as geographic areas where “anchor” institutions and companies cluster and connect with start-ups, business incubators and accelerators. Ideally they’re also physically compact, transit-accessible, and technically wired and offer mixed-use housing, office, and retail. Anchor institutions here include USF, Florida Hospital Tampa, Moffitt Cancer Center and Busch Gardens.

Researchers at Moffitt Cancer Center to study use of Electronic cigarettes
NY City News – June 30
The use of e-cigarettes has risen dramatically since their introduction a decade ago. Recently Moffitt cancer Center has received a $3.6 million grant from the National Institutes of Health to study e-cigarettes.

Alunos ajudam professora do Rio em luta contra câncer no exterior
Olhar Direto – June 30
O tratamento, que é experimental, tem valor a partir de US$ 180 mil, o equivalente a mais de R$ 540 mil. Mas pode sair bem mais caro. O valor exato só será conhecido a partir de 6 de agosto, quando ela passar por uma consulta de avaliação com os médicos do Moffitt Cancer Center, no estado americano da Flórida.

Focus on Geriatric Oncology: CQFD
RTS.ch – June 30
In Switzerland, almost half of new cancer diagnostics concerns of patients over 70 years. The opportunity for Stéphane Délétroz to consider taking oncological care of the elderly. In the interview: Martine Extermann,  professor of oncology at Moffitt Cancer Center in Florida, one of the largest oncology centers in the U.S. (Interview in French)

Moffitt Cancer Center gets $3.6-million grant to study e-cigarettes
FOX 13 – June 29
“Millions of people are using them right now, sales have surpassed $6 billion, and yet we know so little about them,” observed Thomas Brandon, Ph.D., director of the Tobacco Research & Intervention Program at Moffitt Cancer Center.

E-Cigarette Users: Researchers Want to Talk to You
New Port Richey Patch – June 29
That’s why Tampa’s Moffitt Cancer Center is using a $3.6 million grant from the National Institutes of Health to delve into the topic. The center’s Tobacco Research & Intervention Program is heading up a five-year study and needs volunteers from across the country to help out.

For Gaige Robbins, cancer is a laughing matter
Florida Today – June 29
“I refused to let anyone in the (hospital) room if they were crying,” Christa said, adding her son is a jokester. “Everyone was sad, but they didn’t show it. He makes it easy. Gaige makes it easy.” He was treated at the Moffitt Cancer Center in Tampa; one chemotherapy treatment there lasted 96 hours.

New director at University of Florida Heath Cancer Center
The Gainesville Sun – June 29
A Northwestern University faculty member and researcher is the new director of the University of Florida Health Cancer Center. Dr. Jonathan Licht officially starts Oct. 1. But speaking on the phone from a conference in West Palm Beach, Licht said he’s already “drinking from the fire hose,” talking with the directors of the Moffitt Cancer Center in Tampa and the University of Miami’s Sylvester Comprehensive Cancer Center and coming to Gainesville in July for meetings.

Advances save child cancer patients
Valley News via Orlando Sentinel – June 29
“While it’s a generation of information-seekers and technology-users, I don’t know what’s the level of awareness for somebody who had cancer when they were 10 years old and now they’re 25, realizing that some of the anxiety and depression that they may be feeling at their age may be attributed to that cancer experience,” said Gwendolyn P. Quinn of Moffitt Cancer Center in Tampa.

Australia- Prescient Therapeutics makes progress with ovarian cancer drug compound
The Sydney News via MENAFN – June 29
The IND was previously held by an Investigator at the Moffitt Cancer Center in Florida.

More Sensitive Stress-Management Tools Needed for Latina Women With Breast Cancer
Oncology Nursing News – June 26
With an estimated one in every three Latina women facing a diagnosis of cancer in her lifetime, researchers at the Moffitt Cancer Center and their collaborators at the University of South Florida designed a study to illuminate the cancer and stress management experiences of Latina women, with an eye toward designing educational programs to better meet their needs.

Patients With Relapsed/Refractory CLL That Progresses Early on Ibrutinib Have Poor Outcomes
The ASCO Post – June 25
The “foremost” take-home lesson from this study is “the very poor prognosis and overall survival of CLL patients who discontinued the drug regardless of the reason,” according to an accompanying commentary, which was written by Javier Pinilla-Ibarz, MD, PhD, and Julio Chavez, MD, of Moffitt Cancer Center in Tampa, Florida.

Few approved targeted therapies for GE Cancers
Gastroenterology & Endoscopy News – June 2015
Targeted therapies are being investigated in the adjuvant setting after resection, according to Khaldoun Almhanna, MD, MPH, a medical oncologist in the Department of Gastrointestinal Oncology at H. Lee Moffitt Cancer Center.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.